Tarceva Articles
Update: AstraZeneca to do safety trial of Iressa
17 February 2003
AstraZeneca to do safety trial of Iressa
17 February 2003
Tarceva trial in NSCLC enrolled
12 August 2002
Roche stock performance begins to improve
22 July 2002
OSI acquires oncology assets from Gilead in $200 million deal
27 November 2001
OSI starts additional trials of anti-EGFr drug
25 October 2001
Promising data for anti-EGFR therapy Tarceva
15 May 2001
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
